| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |